Cryo-Cell International, Inc. Quarterly report pursuant to Section 13 or 15(d)

Note Payable (Tables)

9 Months Ended

Aug. 31, 2019

As of August 31, 2019 and November 30, 2018, the note payable obligation was as follows:


	August 31, 2019			November 30, 2018
Note payable	$	9,883,433		$	13,208,433
Unamortized debt issuance costs		(178,906	)		(264,923	)

Net note payable	$	9,704,527		$	12,943,510

Current portion of note payable	$	3,100,000		$	3,100,000
Long-term note payable, net of debt issuance costs		6,604,527			9,843,510

Total	$	9,704,527		$	12,943,510

Interest expense on the note payable for the three and nine months ended August 31, 2019 and August 31, 2018 was as follows:


	For the three months ended August 31, 2019		For the nine months ended August 31, 2019
Interest expense on notes payable	$	162,134	$	523,818
Debt issuance costs		28,014		86,014

Total interest expense	$	190,148	$	609,832


	For the three months ended August 31, 2018		For the nine months ended August 31, 2018
Interest expense on notes payable	$	204,609	$	393,254
Debt issuance costs		28,337		79,876

Total interest expense	$	232,946	$	473,130